Introduction: Glandular lesions of the female genital tract (FGT) are quite uncommon compared to squamous lesions. Their cytological diagnosis is difficult because of their architectural and cytological complexity, as well as the lack of experience of many cytopathologists in this field. The aim of this study was to determine the significance of Papanicolaou (Pap) smears in the diagnosis of glandular FGT lesions. Methodology: All Pap smears reported during the period of January 2012 to December 2013 were retrieved. Cytohistopathological correlation was done. Results: Among 7,609 Pap smears, squamous epithelial abnormalities were seen in 110 cases (1.5%) and glandular cell abnormalities in 32 cases (0.42%). Among the glandular abnormalities, we encountered 18 cases of atypical glandular cells (AGC) not otherwise specified, 4 cases of endocervical-type AGC and 4 cases favoring neoplastic-type AGC, 2 cases of adenocarcinoma of the endocervical type, 3 cases of adenocarcinoma of the endometrial type, and 1 case of extrauterine adenocarcinoma. Histopathological correlation was available in 12 cases (37.5%). Eighty-three percent showed premalignant or malignant lesions on histopathology. Conclusion: As glandular epithelial lesions are associated with premalignant and malignant FGT lesions, in patients with cytological diagnosis of glandular epithelial abnormalities, it is mandatory to undergo colposcopic examination with endocervical and endometrial curettage.

Keywords:
Atypical glandular cells, Conventional Papanicolaou smear, Endocervical cancer, Endometrial cancer, Adenocarcinoma
1.
Lai C-R, Hsu C-Y, Li AF-Y: The role of the Pap smear diagnosis: atypical glandular cells (AGC); in Srivastava S (ed): Intraepithelial Neoplasia. Shanghai, InTech, 2012, https://www.intechopen.com/books/intraepithelial-neoplasia/the-role-of-the-pap-smear-diagnosis-atypical-glandular-cells-agc.
2.
Covell JL, Wilbur DC, Guidos B, Lee KR, Chhieng DC, Mody DR: Epithelial abnormalities: glandular; in Solomon D, Nayar R (eds): The Bethesda System for Reporting Cervical Cytology, ed 2. New York, Springer, 2004, pp 123-156.
3.
Ha SY, Cho H, Oh YH, Lee JM, Suh KS: Cytologic and histologic correlation of atypical glandular cells of undetermined significance. J Korean Med Sci 2001;16:214-219.
4.
Marques JP, Costa LB, Pinto AP, Lima AF, Duarte ME, Barbosa AP, Medeiros PL: Atypical glandular cells and cervical cancer: systematic review. Rev Assoc Med Bras (1992) 2011;57:229-233.
5.
Kim S, Suh D, Kim K, Yoon M, Choi K: Clinicopathological significance of atypical glandular cells on Pap smear. Obstet Gynecol Sci 2013;56:76-83.
6.
Rabelo-Santos SH, Sarian LO, Zeferino LC, de Oliveira Zambeli ER, do Amaral Westin MC, et al: Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004;95:618-623.
7.
Frey MK, Gupta D: Evaluation of women with atypical glandular cells on cervical cytology. Gynecol Oncol 2011;36:23-29.
8.
Chan CW, Cheung KB: Clinical significance and management of cervical atypical glandular cells of undetermined significance. Hong Kong Med J 2003;9:346-351.
9.
Gutman G, Bachar R, Pauzner D, Lessing JB, Schejter E: Clinical evaluation of atypical glandular cells of undetermined significance upon cervical cytologic examination in Israeli Jewish women. Br J Cancer 2004;90:2194-2196.
10.
Crasta JA, Chaitra V, Simi CM, Correa M: An audit of cervicovaginal cytology in a teaching hospital: are atypical glandular cells under-recognised on cytological screening? J Cytol 2009;26:69-73.
11.
Adhya AK, Mahesha V, Srinivasan R, et al: Atypical glandular cells in cervical smears: histological correlation and a suggested plan of management based on age of the patient in a low-resource setting. Cytopathology 2009;20:375-379.
12.
Ajit D, Gavas S, Joseph S, Rekhi B, Deodhar K, Kane S: Identification of atypical glandular cells in Pap smears: is it a hit and miss scenario? Acta Cytol 2013;57:45-53.
13.
Jeng CJ, Liang HS, Wang TY, Shen J, Yang YC, Tzeng CR: Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening. Int J Gynecol Cancer 2003;13:518-521.
14.
Scheiden R, Wagener C, Knolle U, Dippel W, Capesius C: Atypical glandular cells in conventional cervical smears: incidence and follow-up. BMC Cancer 2004:4:37.
15.
Chun YK, Hong SR, Kim HS, Kim JY, Kim HS: Histologic correlation of atypical glandular cells in cervical smears. Korean J Pathol 2009;43:453-457.
16.
Bansal B, Gupta P, Gupta N, Rajwanshi A, Suri V: Detecting uterine glandular lesions: role of cervical cytology. Cytojournal 2016;13:3.
17.
Sharma J, Toi PCh, Siddaraju N, Sundareshan M, Habeebullah S: A comparative analysis of conventional and SurePath liquid-based cervicovaginal cytology: a study of 140 cases. J Cytol 2016;33:80-84.
18.
Syrjänen K: Is improved detection of adenocarcinoma in situ by screening a key to reducing the incidence of cervical adenocarcinoma? Acta Cytol 2004;48:591-594.
19.
Schnatz PF, Guile M, O'Sullivan DM, Sorosky JI: Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006;107:701-708.
20.
Wright TC: Management of women with high-grade squamous intraepithelial lesion and atypical glandular cell cervical cytology; in Monsonego J (ed): Emerging Issues on HPV Infections: From Science to Practice. Basel, Karger, 2006, pp 140-146.
21.
American Society for Colposcopy and Cervical Pathology. Reprint April 2013. www.asccp.org/concensus2012.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.